insights_auto
Outlook: 52.8% bullish·5.6% bearish
Go to analysischevron_right
AMGN:NASDAQ
Amgen Inc
၄၆၅.၂၃ US$
arrow_upward
+၁.၀၄%(+၄.၈၁) 1D
၄၆၄.၁၂ US$
arrow_downward
-၀.၂၄% (-၁.၁၁)bedtimeAfter hours
Closed: နို ၉, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Open
၄၆၅.၁၄ US$
High
၄၆၆.၅၄ US$
Low
၄၅၄.၄၆ US$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၂.၈၃ သန်း
Volume
၀.၀၀
Dividend
၂.၁၇%
Quarterly dividend
၂.၅၂ US$
Ex-dividend date
၂၀၂၆ ဩ ၂၁
P/E ratio
၂၆.၉၈
52-wk high
၄၈၃.၉၉ US$
52-wk low
၃၁၂.၅၃ US$
EPS
၁၇.၂၅ US$
Beta
၀.၄၃
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
Open
၄၆၅.၁၄ US$
High
၄၆၆.၅၄ US$
Low
၄၅၄.၄၆ US$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၂.၈၃ သန်း
Volume
၀.၀၀
Dividend
၂.၁၇%
Quarterly dividend
၂.၅၂ US$
Ex-dividend date
၂၀၂၆ ဩ ၂၁
P/E ratio
၂၆.၉၈
52-wk high
၄၈၃.၉၉ US$
52-wk low
၃၁၂.၅၃ US$
EPS
၁၇.၂၅ US$
Beta
၀.၄၃
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Investing.com Canada
·
ပြီးခဲ့သည့် ၄ နာရီ
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
News Corp
·
ပြီးခဲ့သည့် ၈ နာရီ
Amgen Inc. stock rises Monday, still underperforms market
MarketWatch
·
ပြီးခဲ့သည့် ၈ နာရီ
Amgen Inc. stock rises Monday, still underperforms market
Benzinga
·
ပြီးခဲ့သည့် ၁၃ နာရီ
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees၃.၁၅ သောင်း
Founded၁၉၈၀
Headquartersသောင်စင်အုက်စ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websiteamgen.com